Wu Yibing is currently the CEO of Temasek China. His prior roles in Temasek include Joint Head, Technology & Consumer; Joint Head, Enterprise Development Group; and Joint Head, Portfolio Strategy & Risk Group. Prior to joining Temasek, Yibing was President of CITIC Private Equity Funds Management and concurrently served as Chairman and Chief Executive Officer of Goldstone Investment Co. Ltd.
Yibing began his career with McKinsey, rising to become Senior Partner and Head of Asia Pacific M&A Practice. He was also General Manager of McKinsey Beijing, where he was responsible for providing M&A, corporate restructuring and IPO advisory for large Chinese enterprises. He subsequently joined the Lenovo Group, and led the acquisition and integration of the IBM PC business, serving as Chief Strategy Officer, Chief Integration Officer, Chief Transformation Officer / Chief Information Officer of Lenovo Group.
He was later appointed to Lenovo parent Legend Holdings, as Executive Vice President responsible for the overall business operations and overseeing its direct investment business.
Since November 2019, he has been a Board Member of Gavi, the Vaccine Alliances. Yibing also serves on the board of China Social Entrepreneur Foundation. Yibing holds a Doctor of Philosophy degree (PhD) in Biochemistry from Harvard University and a Bachelor of Science degree (BSc.) in Molecular Biology from University of Science and Technology of China.
